rs770654508
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_016138.5(COQ7):c.161G>A(p.Arg54Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000369 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R54W) has been classified as Uncertain significance.
Frequency
Consequence
NM_016138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COQ7 | NM_016138.5 | c.161G>A | p.Arg54Gln | missense_variant | 2/6 | ENST00000321998.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COQ7 | ENST00000321998.10 | c.161G>A | p.Arg54Gln | missense_variant | 2/6 | 1 | NM_016138.5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251488Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135920
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461892Hom.: 0 Cov.: 34 AF XY: 0.0000358 AC XY: 26AN XY: 727248
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary coenzyme Q10 deficiency 8 Pathogenic:2Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Aug 07, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Dec 21, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene, and is associated with primary coenzyme Q10 deficiency 8 (MIM#616733) and autosomal recessive distal hereditary motor neuronopathy 9 (MIM#620402). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to glutamine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (3 heterozygotes, 0 homozygotes). (SP) 0309 - An alternative amino acid change at the same position has been observed in gnomAD (v2) (4 heterozygotes, 0 homozygotes). (I) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0600 - Variant is located in the annotated ubiquinone biosynthesis protein COQ7 domain (DECIPHER). (I) 0708 - Another missense variant comparable to the one identified in this case has conflicting previous evidence for pathogenicity. p.(Arg54Trp) has been reported as compound heterozygous with another missense variant in an individual with distal hereditary motor neuropathy (PMID: 36758993). It has also been reported as a variant of uncertain significance by a clinical testing laboratory, without conclusive evidence against its pathogenicity being provided (ClinVar). (I) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. It has been reported in multiple affected individuals, including four homozygotes and one compound heterozygote (PMIDs: 35782625, 37170631, 37392700). It has also been reported as a variant of uncertain significance by a clinical testing laboratory without further evidence provided (ClinVar). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1001 - This variant has strong functional evidence supporting abnormal protein function. Low ubiquinone level and a severe reduction in COQ7 protein level were shown in the skin fibroblasts from an affected individual who is homozygous for this variant (PMID: 35782625). Similar findings were shown in the fibroblasts from this proband (MRFF-funded mito MDT project). In addition, a higher increase in the respiratory chain complex II+III activity was detected in this proband’s fibroblasts when supplemented with a CoQ analog, compared to the control cell lines (MRFF-funded mito MDT project). Functional studies using a yeast model suggest this variant is hypomorphic (PMID: 37392700). (SP) 1201 - Heterozygous variant detected in trans with a second pathogenic heterozygous variant (NM_016138.4(COQ7):c.319C>T; p.(Arg107Trp)) in a recessive disease. (I) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 31, 2024 | - - |
Neuronopathy, distal hereditary motor, autosomal recessive 9 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 31, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | COQ7: PM2, PM3:Supporting, PS3:Supporting - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at